Biopure Launches Updated Website
Share:
CAMBRIDGE, Mass., Feb. 4 / -- Biopure Corporation (NASDAQ:BPUR) launches an updated and revised website (www.biopure.com) on February 4, 2008. The redesign includes a website for the Oxyglobin veterinary product (www.oxyglobin.com) and the company's South Africa site (www.hemopure.co.za) where Hemopure® [hemoglobin glutamer - 250 (bovine)] is marketed for the treatment of acute anemia in adult surgery patients. New website features include a video case study of Oxyglobin in use, Notes from Zaf, where CEO Zafirelis will comment on Biopure concerns and events, and Dear Zaf where visitors to the site can ask questions of the CEO. Zaf's responses will be posted from time to time on the site.
The revised www.biopure.com site reflects the growing importance of the web as a direct communication tool and the increasing demand for 24/7 information by a variety of people, including the public, the investment community, and the news media.
Biopure Corporation
Biopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Hemopure® [hemoglobin glutamer - 250 (bovine)], or HBOC-201, is approved for sale in South Africa for the treatment of surgical patients who are acutely anemic. Biopure has applied in the United Kingdom for regulatory approval of a proposed orthopedic surgical anemia indication. The company is developing Hemopure for other indications and is supporting the U.S. Navy's government-funded efforts to develop a potential out-of-hospital trauma indication. Biopure's veterinary product Oxyglobin® [hemoglobin glutamer - 200 bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the U.S. Food and Drug Administration and the European Commission, is indicated for the treatment of anemia in dogs. Biopure has sold approximately 190,000 units of Oxyglobin.
Source: Biopure Corporation
CONTACT: Tiana Gorham, Biopure Corporation, +1-617-234-6826, IR@biopure.com; or Investors, Herb Lanzet, H.L. Lanzet Inc., +1-212-888-4570, lanzet@aol.com
Web site: www.biopure.com/
http://www.oxyglobin.com/
http://www.hemopure.co.za/
